Advertisement
Screener

Aura Biosciences, Inc. (AURA) Form D

Aura Biosciences, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2014-01-08: Federal exemption Rule 506(c); Types of securities offered Debt; Date of first sale 2013-08-15; Total offering amount $1,335,000.
  • 2010-09-21: Federal exemption Rule 506; Types of securities offered Debt; Date of first sale 2010-09-08; Total offering amount $1,425,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2014-01-08Rule 506(c)Debt2013-08-15$1,335,000$1,335,000$016
2010-09-21Rule 506Debt2010-09-08$1,425,000$1,425,000$018

Similar stocks

Stock NameCountryMarket CapPE Ratio
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B